Andy Plump

President, Research & Development @ Takeda

About

I'm currently President of Research & Development at Takeda and a member of the company’s board of directors. With nearly three decades of experience across academia and the pharmaceutical industry, I’ve worked across the full spectrum of drug development, from early discovery to patient access. At Takeda, I lead a global R&D organization of nearly 5,000 colleagues. I’ve guided a strategic and cultural transformation that sharpened our focus on innovation and prioritized therapeutic areas with the greatest potential to impact human health. I’ve led multiple programs advancing novel therapies for patients across both rare and more prevalent diseases in oncology, neuroscience and gastrointestinal and inflammation. I’m currently focused on driving our growth and taking an AI-forward approach to preparing our organization for the future of science and medicine. My leadership philosophy is grounded in purpose, curiosity, and collaboration. I’m deeply committed to fostering inclusive environments where the next generation of scientific talent is supported and empowered to lead with integrity and imagination. I serve on several nonprofit boards including the Biomedical Science Careers Program, the Boston Symphony Orchestra and the PhRMA Foundation, where I’m honored to chair the board. I previously served on the board of the Sarnoff Cardiovascular Research Foundation. Outside of work, I’m an avid runner and reader.

Country

United States

City

Boston

Industry

Pharmaceuticals

Skill

Drug Discovery, Clinical Development, Drug Development, Clinical Trials, Clinical Research, Pharmaceutical Industry, Lifesciences

Experience

President, Research & Development

Takeda

2018-12 - Present · 7 yrs 10 mos

Cambridge, MA

Expanding leadership of Takeda's R&D therapeutic area focus to include Rare Diseases in addition to GI, Neuroscience and Oncology, and supporting our broader healthcare aspirations in Vaccines and Plasma-Derived Therapies. We continue to emphasize patient-centric R&D founded on innovative translational science, leveraging a range of therapeutic modalities and an extensive network of external partnerships. Fostering a values-based, agile, and dynamic organizational culture that emphasizes people and operational effectiveness. Having successfully advanced multiple approvals in our core therapeutic areas and transformed our R&D organization over the past several years, we are currently focused on delivering a pipeline of next generation, innovative, life altering therapies for patients.

Chief Medical & Scientific Officer

Takeda

2015-6 - Present · 11 yrs 4 mos

Cambridge, MA

Leading Takeda's global R&D efforts across our core therapeutic areas of GI, Neuroscience and Oncology; with a focus on pipeline, operational effectiveness and people/culture. Driving patient-centric R&D founded on innovative translational science, leveraging a range of therapeutic modalities and an extensive network of external partnerships. Fostering a values-based, agile, and dynamic organizational culture that emphasizes talent development.

Chief Medical & Scientific Officer Designate

Takeda

2015-2 - 2015-6 · 5 mos

Cambridge, Massachusetts

Appointed to lead Takeda's global R&D. Focused on developing a holistic understanding of the rich Takeda history and values as well as its people, science and pipeline. Developed a foundational understanding of Takeda, which linked with a rapidly evolving healthcare landscape and Takeda's Vision 2025, led to a transformation of R&D. Centered on enhancing organizational culture, creating therapeutic areas of focus, building new capabilities and external partnerships.